Professor
Virginia Commonwealth University
Richmond, Virginia
Dr. Mike Hindle is the Peter R. Byron Distinguished Professor in the Department of Pharmaceutics at Virginia Commonwealth University. He has a Pharmacy degree and a Ph.D. in Pharmaceutical Technology, both from the University of Bradford, UK.
He has published over 130 papers, 1 book chapter and served as co-editor of 5 books. He has received funding from NIH, FDA and the Bill and Melinda Gates Foundation together with the pharmaceutical industry. He serves on the editorial board of the Journal of Aerosol Medicine and Pulmonary Drug Delivery and the AAPS PharmSciTech Journal. He is a member of the NIH DBTD study section and has served on over 30 NIH review panels.
He holds 10 U.S. patents and 5 E.U. patents and was inducted as a Fellow of National Academy of Inventors in 2023. Dr. Hindle is co-inventor of technologies that seek to significantly improve pharmaceutical aerosol delivery to the lungs and his research is particularly focused on challenging patient populations such as infants, in which he combines in silico computational fluid dynamics (CFD) with in vitro characterization studies. His group is currently developing a dry powder lung surfactant formulation to treat premature infants with respiratory distress syndrome.
Disclosure information not submitted.
Surfactant Dry Powder Formulations for Premature Babies
Wednesday, October 23, 2024
10:30 AM – 11:00 AM MT